AstraZeneca PLC
06 December 2007
TR-1: NOTIFICATION OF MAJOR INTERESTS IN SHARES
1. Identity of the issuer or the underlying issuer of existing shares to which
voting rights are attached:
AstraZeneca PLC
2. Reason for the notification (place an X inside the appropriate bracket/s)
An acquisition or disposal of voting rights: ( X )
An acquisition or disposal of financial instruments which may result in the
acquisition of shares already issued to which voting rights are attached: ( )
An event changing the breakdown of voting rights: ( )
Other (please specify) : ( )
3. Full name of person(s) subject to the notification obligation:
Capital Group International, Inc.
4. Full name of shareholder(s) (if different from 3.) :
.................
5. Date of the transaction (and date on which the threshold is crossed or
reached if different):
3 December 2007
6. Date on which issuer notified:
5 December 2007
7. Threshold(s) that is/are crossed or reached:
3%
8. Notified details:
.................
A: Voting rights attached to shares
Class/type of shares if possible Situation previous to the Triggering transaction
using the ISIN CODE
Number of shares Number of voting Rights
Ordinary Shares 44,074,040 44,074,040
Resulting situation after the triggering transaction
Class/type of shares if Number of shares Number of voting rights % of voting rights
possible using the ISIN CODE
Direct Indirect Direct Indirect Direct Indirect
Ordinary Shares 43,596,228 43,596,228 2.9873%
B: Financial Instruments
Resulting situation after the triggering transaction
Type of Expiration Date Exercise/Conversion Number of voting rights % of voting rights
financial Period/ Date that may be acquired if the
instrument instrument is exercised/
converted.
N/A
Total (A+B)
Number of voting rights % of voting rights
43,596,228 2.9873%
9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:
.................
Proxy Voting:
10. Name of the proxy holder:
.................
11. Number of voting rights proxy holder will cease to hold:
.................
12. Date on which proxy holder will cease to hold voting rights:
.................
13. Additional information:
Commencing 20 January 2007, The Capital Group Companies, Inc., no longer reports
ownership of securities. Capital Group International, Inc. and Capital Research
and Management Company now report relevant holdings separately for the purposes
of the new DTR Handbook.
14. Contact name:
Justin Hoskins - Assistant Secretary
15. Contact telephone number:
020 7304 5112
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.